• 733 Citations
  • 14 Scopus h-Index
1992 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Scott Fosko is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014

Bray, H. N., Simpson, M. C., Zahirsha, Z. S., Brinkmeier, J. V., Walen, S. G., Fosko, S. W. & Osazuwa-Peters, N., Jan 1 2019, (Accepted/In press) In : JAMA Otolaryngology - Head and Neck Surgery.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Lentigo maligna-challenges, observations, imiquimod, confocal microscopy, and personalized treatment

    Fosko, S., Navarrete-Dechent, C. P. & Nehal, K. S., Aug 1 2018, In : JAMA Dermatology. 154, 8, p. 879-881 3 p.

    Research output: Contribution to journalReview article

    3 Scopus citations

    Modified Slow Mohs Technique for Treatment of Cellular Neurothekeoma of the Lip in a Pediatric Patient

    Xu, K. Y., Vidal, C., Slutsky, J., Fosko, S. & Plikaitis, C. M., Mar 1 2017, In : Dermatologic Surgery. 43, 3, p. 446-449 4 p.

    Research output: Contribution to journalLetter

    1 Scopus citations

    Primary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature

    Stuart, L. N., Tipton, R. G., DeWall, M. R., Parker, D. C., Stelton, C. D., Morrison, A. O., Coleman, L. W., Fosko, S., Vidal, C. I., Yadira Hurley, M., Deeken, A. H. & Gardner, J. M., Aug 1 2017, In : Journal of Cutaneous Pathology. 44, 8, p. 713-721 9 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

    Dréno, B., Kunstfeld, R., Hauschild, A., Fosko, S., Zloty, D., Labeille, B., Grob, J. J., Puig, S., Gilberg, F., Bergström, D., Page, D. R., Rogers, G. & Schadendorf, D., Mar 1 2017, In : The Lancet Oncology. 18, 3, p. 404-412 9 p.

    Research output: Contribution to journalArticle

  • 44 Scopus citations